Clinical Trials
2 trialsNCT06038526 2026-05-20
Evaluation of Canakinumab in High-Risk Former-Smokers
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT05304390 2024-12-02
A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle
Fred Hutchinson Cancer Center
Phase NA Terminated